Upload
others
View
11
Download
0
Embed Size (px)
Citation preview
The BioTech Pharma Summit29 - 30 NOV 2021, Porto, Portugal
Antibody Engineering & Therapeutics
The next-generation antobody therapeutic is
majorly driven by the development of
monoclonal antibodies and frowing chronic
diseases prevalence. The increasing
population, urbanization, and changing lifestyle
are favouring the anti-generation antibody
therapeutics market growth. Increasing
government supports through investments
and focus of the pharmaceutical &
biotechnology firms on the development of
antibodies for future usage of chronic disease
are further accelarating the next generation
therapeutic market.
01DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Nick Hutchinson, Group lead at FUJIFILMAntibody Manufacturing Strategies during a Pandemic
09:00 - 09:30Speed Networking
09:30 - 10:00 — Kathryn Ching, Research Investigator at LigandHeavy Chain Only Antibodies to SARS-CoV-2
10:00 - 10:30 — Monica Berrondo, CEO at MacromoltekTaking antibody candidate generation from the lab to the cloudwith de novo computational design
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — César de la Fuente, Assistant Professor at UPennAntibiotic Discovery by Means of Computers
11:30 - 12:00 — Nicolas Camper, Group Leader at AbzenaDesigning and Developing Next-Generation Antibody-Drug Conjugate Medicines
12:00 - 12:30 — Benjamin Doranz, CEO at Integral MolecularLessons in Discovering Antibodies against GPCRs, Ion Channels, and Transporters
12:30 - 13:00 — Hitto Kaufmann, CSO, Senior VP at PierisDeveloping next-generation therapeutic proteins as highly targeted therapies in immuno-oncology and respiratory disease
13:00 - 14:00Lunch Break
14:00 - 14:30 — Marc A. van Dijk, CTO at Agenus Inc.Discovery and engineering of Immuno-oncology antibodies– Effective formats and impactful combinations
14:30 - 15:00 — Ilse Roodink, CSO at ImmunoPrecise AntibodiesTopic to be announced
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Sicco H. Popma, President & CEO at IO BiosciencesGEMS-TM system – a plug-and-play system for biomanufacturing
16:00 - 16:30 — Miriam Bujny, CDO at Sapreme TechnologiesAntibody-targeted cytoplasmic delivery of fusion proteins and antibody fragments using Sapreme’s endosomal escape enhancers
16:30 - 17:00 — Heather Schwoebel, SVP at Alloy Therapeutics, Inc.Topic to be announced
17:00 - 17:30 — Oren Beske, Business & Biology at ATUMTopic to be announced
17:30 - 18:00 — Panel DiscussionComputational Modeling of Antibody-Antigen Interactions
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Antibody Engineering & Therapeutics
02DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Kevin Heyries, Co-founder at AbCelleraResponding to the COVID-19 Pandemic with Antibodies, Small Molecules Drugs and Vaccines
09:00 - 09:30 — Vu Truong, Founder at Aridis Pharmaceuticals, Inc.Topic to be announced
09:30 - 10:00 — Katharina B.Frey, Head of Protein Eng. at ApogenixTopic to be announced
10:00 - 10:30 — Harald Kolmar, Professor at TU of DarmstadtThe art of making multifunctional antibodies: therapeutic opportunities and technical challenges
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Soraya Hölper, Lab Head at SanofiChallenges in characterization and developability of multispecific antibodies
11:30 - 12:00 — Katherine Harris VP at Teneobio, Inc.Modulating the Immune System with Multi-Specific Antibodiesin Cancer
12:00 - 13:00 — Panel DiscussionAntibody Selection and Screening in Early Discovery
13:00 - 14:00Lunch Break
14:00 - 14:30 — Click here to submit your PosterTOP–5 Poster Presentations (5min. On Stage)
14:30 - 15:00 – Paul W.H.I. Parren, Exec VP at Lava TherapeuticsBispecific γδ-T cell engagers for the treatment of cancer
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 – Mattias Levin, Sr Scientist at Alligator BioscienceNeo-X’: A bispecific antibody concept targeting CD40 and tumor antigens to enhance neoantigen cross-presentation and T cell priming
16:00 - 16:30 – Stefan Zielonka Associate Director at MerckAffinity maturation of B7-H6 translates into enhanced NK cell-mediated tumor cell lysis and improved proinflammatory cytokine release of bispecific immunoligands via NKp30 engagement
16:30Chairman's closing remarks
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Antibody Engineering & Therapeutics
Inhalation & Respiratory Drug Delivery
A recent report from PhRMA found America’s
biopharmaceutical companies are developing
about 130 new medicines for the millions of
patients affected by respiratory diseases: chronic
obstructive pulmonary disease (COPD), cystic
fibrosis, pneumonia, and asthma. These medicines
represent critical advancements in respiratory care
and improving quality of life. In addition to the
drugs, devices delivering those products are being
designed to improve the quality of life for an aging
population, children, and those who tend not to
comply to dosing regimens because they don’t
know how to use the device.
01DAY
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Arkadiusz Kuczaj, Manager at Philip Morris InternationalAccurate dosimetry predictions for evolving liquid aerosol delivery
PART II: Inhalation Formulation Solutions & Technology
11:30 - 12:00 — Beatriz Noriega Fernandes, Scientist at HovioneHigh Dosage DPI – formulation and process development considerations
12:00 - 12:30 — Jeffry Weers, CTO at Respira Therapeutics, Inc.Musings on High Dose Powder Delivery
13:00 - 14:00Lunch Break
14:00 - 14:30 — Sven Stegemann, Professor at TU GrazIncreasing the drug load in capsule based DPI drug delivery systems
14:30 - 15:00 — Martin Wing-King, Director at Quotient Sciences
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
PART I: The challenges of developing inhalation drugs
08:30 - 09:00 — Jörg Schiewe, Head of Global CMC Experts at Boehringer Ingelheim PharmaScience base and challenges of therapeutic equivalence of respiratory products
09:00 - 09:30Speed Networking
09:30 - 10:00 — Thomas Secher, Research scientist at INSERMThe biological barriers to consider for the development of inhaled biotherapeutics
10:00 - 10:30 — Aernout van Haarst, Director at CelerionEarly Phase Clinical Trials for Inhaled Drugs - Challenges and Opportunities
Formulation Development Challenges and Pitfalls When Developing Dry Powder Inhalers
15:00 - 15:30Afternoon Coffee & Networking Break
PART III: Regulatory pathways for inhaled therapies
15:30 - 16:00 — Dino Farina, Founder and CEO at Proveris ScientificUsing a New Human Realistic Approach to In Vitro Characterization to Better Predict In Vivo Performance of Inhaled Aerosols
16:00 - 16:30 — Marco Laackmann, Director at Harro HöfligerGet it right first time: Inhaler technology and manufacturing
16:30 - 17:30 — Panel DiscussionAsthma inhalers: what next for the drug delivery tech?
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Inhalation & Respiratory Drug Delivery
02DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
PART IV: New Approaches to Treating Respiratory Diseases
08:30 - 09:00 — Masahiro Sakagami, Professor at VCU Schoolof PharmacyTopic to be announced
09:00 - 09:30 — Tonya Winders, CEO at Allergy & Asthma NetworkShared Decision Making to Improve Adherence in Severe Asthma
09:30 - 10:00 — Fakhrul Ahsan, Professor at the TTUHSCInhalation therapy for pulmonary arterial hypertension, a pulmonary vascular disease
10:00 - 10:30 — Peter Robbins Professor at University of OxfordOptimising surrogate outcome measures for respiratory trials
10:30 - 11:00Morning Coffee & Networking Break
PART V: New analytical insights into dry powder formulations for inhalation
11:00 - 11:30 — Wayland Rushing, Director at EurofinsTopic to be announced
11:30 - 12:00 — Click here to registerSpeaking Sponsorship Available - Have your talk here
12:00 - 13:00 — Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
13:00 - 14:00Lunch Break
14:00 - 14:30 — Click here to submit your PosterTOP–5 Poster Presentations (5min. On Stage)
PART VI: New Approaches to Inhalation Product Development and Production
14:30 - 15:00 — Michael Castagna, CEO at MannKind CorporationTopic to be announced
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Mark Milton-Edwards Head of Product & Health Solutions - Digital Health at Teva PharmaceuticalsDevelopment of an Integrated Digital Health Product (DigihalerTM)
16:00Chairman's closing remarks
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Inhalation & Respiratory Drug Delivery
Pharmacovigilance & Drug Safety
With the augmented incidence of diseases, and
the non-medical use of prescription drugs, the
incidence of drug abuse has increased
enormously in the recent years, which is
apparent with the excess documentation of
adversities and drug toxicities. In this context,
the drug safety and pharmacovigilance has
emerged as a dynamic clinical and scientific
discipline to provide adequate information and
ensure health safety by the joint interaction of
doctors and patients in choosing appropriate
treatment method and drug.
01DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Margherita D'Antuono, Director at Italfarmaco GroupPSMF in a global environment: compliance with local requirements
09:00 - 09:30Speed Networking
09:30 - 10:00 — Susana Almeida, Director at Medicines for EuropeHow to achieve 3S pharmacovigilance (smart, strategic, selective): view from the generic sector
10:00 - 10:30 — Salvatore Cicirello, Head of Safety Science at Bristol Myers SquibbAdoption of Artificial Intelligence in Pharmacovigilance: a framework for the development of cognitive services and the role of the Drug Safety Professional
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Valentina Mancini, Director at Shionogi EuropeDigital Media, marketing projects, e-commerce and other business initiatives: opportunities and challenges for PV
11:30 - 12:00 — Andrea Oliva, Head of Pharmacovigilance at MylanHow Pharmacovigilance could support business
12:00 - 12:30 — Julia Appelskog, Head of QPPVs & Safety Consulting Services at TFSHow to define PV strategy and build an effective Regulatory Intelligence function
12:30 - 13:00 — Massoud Toussi, Senior Principal at IQVIAPost authorization safety studies (PASS)
13:00 - 14:00Lunch Break
14:00 - 14:30 — Tjark Reblin, Global Head at Vifor Pharma GroupA framework for Safety evaluation and risk managment
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Marie-Laure Kürzinger, Benefit-Risk Expert at SanofiStructured and Quantitative Benefit-Risk evaluation for medicinal products: how can it make a difference?
16:00 - 16:30 — Calin Lungu, CEO at DDCS S.A.EudraVigilance, XEVMPD, EVDAS, SPOR, EMA unique account news
16:30 - 17:00 — Panel DiscussionTopic to be announced
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Pharmacovigilance & Drug Safety
02DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Claudia Nolte, Director at CSL BehringRemote PV Audits and Inspections
09:00 - 09:30 — Uwe Gudat, Head of Medical Affairs & CSPV at Fresenius KabiTopic to be announced
09:30 - 10:00 — Robert Weber, Product Mgmt Director at OracleNew Trends in Signal Detection and Management
10:00 - 10:30 — Dennis Vargo, Vice President and Head of Drug Safety and Pharmacovigilance at AkebiaThe Evolution of the Safety Scientist
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Anupam Agarwal, Vice President at Zogenix, Inc.Cardiovascular safety issues during phase III-IV for non-cardiovascular trials.
11:30 - 12:00 — Mircea Ciuca, Global Therapeutic Area Head - Global Clinical Safety and Pharmacovigilance at CSL BehringTopic to be announced
12:00 - 13:00 — Panel DiscussionTopic to be announced
13:00 - 14:00Lunch Break
14:00 - 14:30 — Click here to submit your PosterTOP–5 Poster Presentations (5min. On Stage)
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 – Martin Holm-Petersen, CEO at InsifeMultivigilance – re-inventing the vigilance system for drug safety with devices, complaints, counterfeits etc.
16:00 - 16:30 – Budhesh Dhamija, Senior Manager, Regulatory Intelligence and Policy – Europe at CSL BehringTopic to be announced
16:00Chairman's closing remarks
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Pharmacovigilance & Drug Safety
Pre-filled Syringes & Injectables
The market driver of the highest stature for the global
prefilled syringes market growth is the increase in
chronic ailments and demand for advanced medical
facilities. The rise in diabetes, cancer, and
cardiovascular disorders is also causing market growth.
Other important market drivers are increasing research
& development (R&D), demand for convenient drug
delivery methods, elimination of dosing errors, need
for more effective methods for unit dose medication,
greater dose precision, suitability for home use, and
initiatives from different governments around the
world to boost healthcare sector.
01DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Min Wei, Director at AstraZenecaInnovations in drug delivery and combination devices
09:00 - 09:30Speed Networking
09:30 - 10:00 — Amber Witteman, Founder at EPIWatchNext generation design and materials for PFS
10:00 - 10:30 — Click here to registerSpeaking Sponsorship Available
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Jakob Lange, Account Director at Ypsomed AGUser-driven product development: Focus on self-injection devices
11:30 - 12:00 — Click here to registerSpeaking Sponsorship Available
12:00 - 12:30 — Beate Treffler, Manager at Avient CorporationExtractable metals: potential sources in your Prefilled Syringes, risk management and change control
13:00 - 14:00Lunch Break
14:00 - 14:30 — Clemens Günther, Director at Bayer AGNonclinical safety evaluation of extractables and leachables when developing a pre-filled syringe drug device combination product
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Tudor Arvinte Professor at University of Geneva, Switzerland, CEO of TherapeomicTopic to be announced
16:00 - 16:30 — Click here to registerSpeaking Sponsorship Available
16:30 - 17:00 — Panel DiscussionTopic to be announced
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Pre-filled Syringes & Injectables
02DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Aaron Johnson, Vice President of Marketing and Customer Strategy at AccumoldInnovation through Miniaturization and Micro Injection Molding
09:00 - 09:30 — Ashley Reynolds, Pharma Technology Sales and Marketing at Körber Group companyModular Feeding Systems for Parenterals, such as Pre-filled Syringes and Injection Devices
09:30 - 10:00 — René Holm, Head and Scientific Director at The Janssen Pharmaceutical Companies of Johnson & JohnsonDeveloping suspensions as long acting injectables
10:00 - 10:30 — Joël Richard, Chief Development Officer at MedinCellLong-Acting Injectable Formulation Technologies: Challenges and Opportunities for the Delivery of Fragile Molecules
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Andreas Kerschbaumer, Senior Technical Manager at Sandoz GmbHAseptic Production and IPC
11:30 - 12:00 — Click here to registerSpeaking Sponsorship Available
12:00 - 13:00 — Panel DiscussionTopic to be announced
13:00 - 14:00Lunch Break
14:00 - 14:30 — Click here to submit your PosterTOP–5 Poster Presentations (5min. On Stage)
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Benedikt Reichart, Global Business Development Manager at Fresenius Kabi AustriaAseptic competence at Fresenius Kabi
16:00 - 16:30 — Click here to registerSpeaking Sponsorship Available
16:30Chairman's closing remarks
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Pre-filled Syringes & Injectables
Gut-Brain Axis
The Gut-Brain Axis event, brings together leading
scientists, physicians, and senior leaders to
explore the potential insights into the
Microbiota–Gut–Brain Axis, the Human
Microbiome Market that exhibits significant
potential in the near future.
The ability of gut microbiota to communicate
with the brain is emerging as an exciting concept
in health and disease. Mounting evidence, mostly
from rodent studies, suggests that gut microbes
help shape normal neural development, brain
biochemistry, and behaviour.
01DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Pierre Lestage, Chief Executive Officer at NeribiOmGut brain axis and neurological diseases
09:00 - 09:30Speed Networking
09:30 - 10:00 — Click here to registerSpeaking Sponsorship Available
10:00 - 10:30 — Jennifer K. Spinler, Instructor at Texas Children’s Microbiome Center & Baylor College of MedicineDo plant-derived exosomes regulate the gut microbiome?
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Rochellys Diaz Heijtz, Associate Professor and Group Leader in the Department of Neuroscience at Karolinska InstitutetTopic to be announced
11:30 - 12:00 — Shahram Lavasani, Founder / CEO at ImmuneBiotechTargeting the brain-gut-microbiome axis by ImmuneBioticsTM, a new therapeutic avenue for management of multiple sclerosis
12:00 - 12:30 — Javier Ochoa-Repáraz, Assistant Professor at Eastern Washington UniversityThe gut microbiome as a therapeutic venue for inflammatory diseases of the central nervous system (CNS)
12:30 - 13:00 — Satya Prakash, Professor at McGill UniversityNovel Microbiome Approach For Management of Alzheimer Diseases
13:00 - 14:00Lunch Break
14:00 - 14:30 — Click here to registerSpeaking Sponsorship Available
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Wouter de Jonge, Professor of Neurogastroenterology at AMC, CoFounder of Gut ResearchThe gut-brain and brain-gut axes in human disease
16:00 - 16:30 — Click here to registerSpeaking Sponsorship Available
16:30 - 17:00 — Panel DiscussionClinical Trials in the Gut-Brain Axis: Challenges & Opportunities
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Gut-Brain Axis
02DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Jane A. Foster, Associate Professor at McMaster Uni.Harnessing the Potential of Microbiota-related Therapies for Brain Health
09:00 - 09:30 — Rohan F. Hastie, President & CEO at MetabolonDeciphering the Gut-Microbiome-Brain Axis Relationship with Metabolomics
09:30 - 10:00 — Christian Roghi, Director at CosmosIDIntestinal microbiome medicinal product (IMMP): establishing a licensed platform to create novel products
10:00 - 10:30 — Martha Carlin, CEO at The BioCollectiveTo be announced
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Sergueï O. Fetissov, Professor of physiology at Rouen University and co-founder of TargEDys.Microbiome Mediated Appetite Regulation - First Experiences with EnteroSatys
11:30 - 12:00 — Click here to registerSpeaking Sponsorship Available
12:00 - 13:00 — Panel DiscussionGut microbiota and its implications for psychiatry: Conclusions and Future Directions for Research
13:00 - 14:00Lunch Break
14:00 - 14:30 — Click here to submit your posterTOP–5 Poster Presentations (5min. On Stage)
14:30 - 15:00 — Marcus Böhme, R&D Specialist at Nestlé ResearchDiet & the Gut-Brain Axis: from concept to product
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Georges Rawadi, CEO at LNC TherapeuticsFrom Nutrition to Therapy: Commercialising the Therapeutic Potential of The Microbiome in the Field of Metabolic Diseases
16:00 - 16:30 — Domingo Barber, Director at Universidad San Pablo MadridSystemic barrier damage and biomarkers connected to inflammation and the potential role in dysbiosis
16:30Chairman's closing remarks
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Gut-Brain Axis
Probiotics, Human & Skin Microbiome
Probiotics as a key functional ingredient in targeting
major skin concerns (acne, blemishes, wrinkles etc)
is gaining popularity in research, with increasing
clinical evidence pointing towards their efficacy.
Probiotics – products containing live bacteria –
comprise of only a small portion of commercialized
cosmetic products and hold great untapped
potential in the skincare market. However,
implementing live bacteria into mainstream
products is not easy. Bacterial products require
aseptic conditions, a challenge for packaging, and
often have a short shelf life so do not last long.
01DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Per Falholt, Director at Novo Nordisk FoundationSkin Care and microbes
09:00 - 09:30Speed Networking
09:30 - 10:00 — Chrysi Sergaki, Microbiome Scientist at National Institute for Biological Standards and ControlDeveloping global standards for the microbiome field
10:00 - 10:30 — Radhika Bongoni, Business Developer at BaseClearPre-pro-postbiotics and role in modulating our microbiome – status & case studies
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Huiying Li, Associate Professor at University of California, Los AngelesDissecting the human skin microbiome in health and disease
11:30 - 12:00 — Alexandre Passioukov, VP Translational Medicineat Pierre FabreIs human skin microbiota a goldmine for personalized diagnostic tests?
12:00 - 12:30 — David Berry, General Partner at Flagship PioneeringIntegrated gut biology
12:30 - 13:00 — Momo Vuyisich, Founder and CSO at ViomePlatform that allows to study the connections among diet, gut microbiome, immune system, human physiology, and health/disease states
13:00 - 14:00Lunch Break
14:00 - 14:30 — Denise Kelly, Investment Advisor at SeventureTranslating the Human Gut Microbiome- Progress through Innovation and Investment
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Fabio Piccini Co-founder at Progetto Microbioma ItalianoKetogenic diet and the gut microbiota
16:00 - 16:30 — Pavlovic Guillaume Head of Unit at PHENOMIN-ICSStudying the variability of intestinal microbiome in mice to better understand the Human microbiome
16:30 - 17:00 — Magnus Sjögren, Associate Professor at Uni. of GothenburgAn abnormal microbiome in Anorexia Nervosa – implications for interventions
17:00 - 17:30 — Panel DiscussionThe development of new therapies in skin microbiome
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Probiotics, Human & Skin Microbiome
02DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Lionel Breton, Scientific Director at L’OrealConsidering the Microbiome Interorgans Axis (MIA) as a future option in Health & Diseases
09:00 - 09:30 — Veronika Oudova, Co-founder and CEO at S-BiomedicS-Biomedic approach of direct skin microbiome modulation
09:30 - 10:00 — Click here to registerSpeaking Sponsorship Available
10:00 - 10:30 — Elinor McCartney, President for Pen & Tec ConsultingFeeding your brain & skin: will European Regulation let psychobiotics & skinbiotics live up to our expectations?
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Frédéric Moens, Head of R&D at ProDigestThe probiotic potential of SYMPROVE: an in-depth study using the SHIME® technology platform
11:30 - 12:00 — Click here to registerSpeaking Sponsorship Available
12:00 - 13:00 — Panel DiscussionPre and Probiotics: A Shift from Pharmaceuticals to Nutraceuticals
13:00 - 14:00Lunch Break
14:00 - 14:30 — Click here to submit your posterTOP–5 Poster Presentations (5min. On Stage)
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Jean-Pol Warzée, President at European Scientific League for Probiotics – ESLPQuality control of probiotics and internationalisation of the ESLP initiative
16:00 - 16:30 — Adam Baker, Director at Chr. Hansen HoldingTopic to be announced
16:30 - 17:00 — Peter Cartwright Human Microecology SpecialistPre-clinical selection of probiotics strains: Six simple steps
17:00Chairman's closing remarks
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Probiotics, Human & Skin Microbiome
Aseptic Processing Technology
The aseptic processing industry has seen many
changes during its progression towards the
21st century. With advances in innovative
therapeutic manufacturing such as ATMPs,
pragmatic barrier system applications,
adaptability and modularity in fill finish,
robotics and automation, small and agile
product manufacturing, just to name a few. In
2018, the global aseptic processing market was
valued over $56 trillion and is estimated to
increase in net revenue upwards $124 trillion
by 2027, with a CAGR growth of 9.18%.
01DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Matthias Angelmaier, Global Product Manager Isolator Technology at Syntegon Technology GmbHVaccines for the world - insights into design and execution of a BSL2 fill-finish facility
09:00 - 09:30Speed Networking
09:30 - 10:00 — Susan Cleary, Director at Novatek InternationalLearn How to Trend & Analyze Environmental Monitoring Data
10:00 - 10:30 — Click here to registerSpeaking Sponsorship Available
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Thomas Becker, Director Site Quality at RecipharmInnovative and Agile Approaches in the Aseptic Manufacturingof Lyophilised Vialed Drug Products
11:30 - 12:00 — James L. Drinkwater, Head of GMP compliance & Aseptic process integration at F ZielCombined ATMP Viral vector formulation and filling on an integrated Barrier technology platform
12:00 - 12:30 — Mostafa Nakach, Head of pharmaceutical engineering section within Pharmaceutical sciences department at SanofiDe-risking the fill and finish process of biotech products
12:30 - 13:00 — Click here to registerSpeaking Sponsorship Available
13:00 - 14:00Lunch Break
14:00 - 14:30 — Magnus Gustafsson, Head of Global Business Development at BiovianClosed process for aseptic fill without possibility for sterile filtration
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Sue Behrens, Professor in Bioprocessing and Director, Amgen Bioprocessing Center at Keck Graduate InstituteTopic to be announced
16:00 - 16:30 — Click here to registerSpeaking Sponsorship Available
16:30 - 17:00 — Panel DiscussionTopic to be announced
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Aseptic Processing Technology
02DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
08:30 - 09:00 — Harald Stahl, Sn. Director Innovation and Strategy at GEAContinuous Processing opening new possibilities
09:00 - 09:30 – Christian Kollecker, Business Unit Leader Pharma Liquid & Aseptic at Harro HöfligerAseptic bag processing: bridging the gap
09:30 - 10:00 — Keith W. Dodson, VP of Business Development at AST Use of Robotics in Flexible Format Aseptic Filling
10:00 - 10:30 — Kate Coleman, Director/Senior Consultant Qualityand Compliance at PharmaLexImplementation of an efficient QRM program
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Walid El Azab, Sn. Manager Technical Service at STERISContamination Control Strategy, an Implementation approach
11:30 - 12:00 — Ken Nagai Director at Airex Co.Decontamination 5.0 -Ultradecon® and Enzyme Indicator
12:00 - 13:00 — Panel DiscussionTopic to be announced
13:00 - 14:00Lunch Break
14:00 - 14:30 — Click here to submit your PosterTOP–5 Poster Presentations (5min. On Stage)
14:30 - 15:00 — Click here to registerSpeaking Sponsorship Available
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Richard Denk, Sn. Consultant Aseptic Processing & Containment at SKAN AGContamination and Cross Contamination Control during Aseptic Manufacturing
16:00 - 16:30 — Click here to registerSpeaking Sponsorship Available
16:30Chairman's closing remarks
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
Aseptic Processing Technology
CDx / Biomarkers & Biobanking
CDx market is growing due to continuous
advancement in medical technology both for the
diagnosis and the treatment of patients. Rise in the
prevalence of diseases like cancer & HIV is fueling
to the growth of companion diagnostics as it assist
in determining the patient specific dose and drugs.
The Biomarkers Market is expected to register a
CAGR of 10.28% during the assessment period of
2020 to 2027, to reach USD 4,5B by 2027. With an
increasing incidence rate of chronic and
life-threatening diseases, the demand for precise
diagnostic procedures is increasing.
01DAY
11:30 - 12:00 — Shona Kerr, Project Manager at MRC Human Genetics Unit, EdinburghTopic to be announced
12:00 - 12:30 — Click here to registerSpeaking Sponsorship Available
13:00 - 14:00Lunch Break
PART II: CDx & Biomarkers
14:00 - 14:30 — Yong-Jie Lu MD, Professor in Molecular Oncology at Queen Mary University of LondonCirculating biomarkers for cancer diagnosis and precision medicine
14:30 - 15:00 — Carla Leibowitz, Chief BD Officer at Paige.AIDigital biomarkers and the latest development in the pathology space
15:00 - 15:30Afternoon Coffee & Networking Break
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
PART I: Biobanking
08:30 - 09:00 — Jim Vaught, EIC at Biopreservation & BiobankingAntibody Manufacturing Strategies during a Pandemic
09:00 - 09:30Speed Networking
09:30 - 10:00 — Andres Metspalu, Professor at University of TartuFrom Biobanking to Personal medicine and Prevention
10:00 - 10:30 — Karine Sargsyan, COO at Biobank GrazTopic to be announced
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Daniel Grölz, Scientific Associate Director R&D at QIAGENNeed for workflow solutions from sample collection to diagnostic assay
15:30 - 16:00 — Lauren C. Leiman, Executive Director at BloodPACBloodPAC Consortium: An Update on Establishing Standards, Accelerating Data Sharing and Analysis
16:00 - 16:30 — Matthew Griffin, Professor of Transplant Biology at National University of Ireland, GalwayBiomarkers in transplantation
16:30 - 17:00 — Sophie Brouard, Director of Research at CNRSImmunological signatures as biomarkers in corneal transplantation
17:00 - 17:30 — Christa Noehammer Senior Scientist at AITEpigenetic biomarkers for Type 2 Diabetes from plasma - and saliva derived extracellular vesicles
17:30 - 18:00 — Jörg Engelbergs, Scientific-Regulatory Expert at Paul-Ehrlich-Institut & European Medicines AgencyRegulatory-scientific challenges for predictive biomarker based personalized medicines
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
CDx / Biomarkers & Biobanking
02DAY
08:00 - 08:20Registration & Welcome Coffee
08:20 - 08:30Chairman's Opening Address
PART II: CDx & Biomarkers
08:30 - 09:00 — Jane Wilkinson, Senior Director at Broad InstituteTopic to be announced
09:00 - 09:30 — Marianne Oulhen, Head of Projects at Gustave RoussyTopic to be announced
09:30 - 10:00 — Matt Humphries, Scientific Lead at Queen’s University BelfastMultiplexing for Clinical Diagnostics: The Next Generation of Molecular Pathology
10:00 - 10:30 — Catherine Alix-Panabières, Director LCCRH at the University Medical Center of MontpellierLiquid Biopsy: From Discovery to Clinical Application
10:30 - 11:00Morning Coffee & Networking Break
11:00 - 11:30 — Selina Gaertner, Medical Affairs Manager EMEA at HTG Molecular DiagnosticsOvercoming the challenges of RNASeq with extraction-free, low sample input gene expression profiling by the HTG EdgeSeq WTA
11:30 - 12:00 — Christian Werno, Research group leader at Fraunhofer InstituteClinical applications of liquid biopsies
12:00 - 13:00 — Panel DiscussionTopic to be announced
13:00 - 14:00Lunch Break
PART II: Biobanking
14:00 - 14:30 — Click here to submit your PosterTOP–5 Poster Presentations (5min. On Stage)
14:30 - 15:00 — Pasquale De Blasio, Exec. VP and COO at ISENET BiobankingBiobank - an overview
15:00 - 15:30Afternoon Coffee & Networking Break
15:30 - 16:00 — Brent Schacter, Professor Emeritus at Rady College of Medicine, University of ManitobTopic to be announced
16:00 - 16:30 — Vincent von Walcke-Wulffen, CEO at BioKryoBuilding a GMP Biobanking Network in Europe
16:30 - 17:00 — Peadar Mac Gabhann, MD at Biostór IrelandVISICORT Foundation Biobank
17:00 - 17:30 — Panel DiscussionTopic to be announced
17:30Chairman's closing remarks
20:00 - 22:30 — The BioTech Pharma Summit 2021Gala Dinner
CDx / Biomarkers & Biobanking
www.biotechpharmasummit.com